An Italian investigation of pathogens causing COPD exacerbation and their resistance to common antibiotics (The EOLO Study)

Multidisciplinary Respiratory Medicine

Volumn 3, Issue 1, 2008, Pages 13-21

  Sanguinetti, Claudio M ^a,i   Corrao, Giovanni ^b   Kilama, Michael Ochan ^c   De Benedetto, Fernando ^d   Donner, Claudio F ^e   Marchese, Anna ^f   Nicoletti, Giuseppe ^g   Schito, Gian Carlo ^f   Speciale, Annamaria ^g   Sevieri, Gianfranco ^h  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Italfarmaco Spa   (Italy)

^d SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^e Centro Diagnostico   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g UNIVERSITY OF CATANIA   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ UO di Pneumologia   (Italy)

Author keywords

Acute exacerbations of COPD (AECOPD); Antibiotic resistance; General practitioners; Pathogens

Indexed keywords

EID: 54249110381     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proc Am Thorac Soc 2004;1:109-114.
2. Ball P, Harris JM, Lowson D, Tillotson G, Wilson R. Acute infective exacerbations of chronic bronchitis. Q J Med 1995;88:61-68.
3. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 2000;117(Suppl):380-385.
4. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther 1999;21:576-591.
5. Miravitlles M, Murio C, Guerrero T, Gisbert R. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2000;121:1449-1455.
6. ISTAT. Indagine multiscopo sulle famiglie. Roma, 1994.
7. Viegi G, Carrozzi L, Pistelli F, Scognamiglio A, Baldacci S. Prevalenza e fattori di rischio acquisiti delle BPCO. In: Giuntini C, Grassi V. Il volto della BPCO che cambia. I Quaderni. UTET Periodici Ed. Torino, 2001:49-66.
8. ISTAT. Cause di morte, anno 1994. Edizione 1997.
9. Ministero Italiano della Salute, anno 2000.
10. Lucioni C, Donner CF, De Benedetto F, Lusuardi M, Mazzi S, Paggiaro PL, Sanguinetti CM. I costi della broncopneumopatia cronica ostruttiva:la fase prospettica dello studio ICE (Italian Costs for Exacerbations in COPD). Pharmacoeconomics. Italian Research Articles 2005;7:119-134.
11. Adams SG, Anzueto A. Antibiotic therapy in acute exacerbations of chronic bronchitis. Semin Respir Infect 2000;15:234-247.
12. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
13. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52Suppl5:S1-28.
14. Snow V, Lascher S, Mottur-Pilson C; Joint Expert Panel on Chronic Obstructive Pulmonary Disease of the American College of Chest Physicians and the American College of Physicians-American Society of Internal Medicine. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2001;134:595-599.
15. Schito GC, Debbia EA, Marchese A. The evolving threat of antibiotic resistance in Europe: new data from Alexander project. J Antimicrob Chemother 2000;46:3-9.
16. Celli BR, MacNee W, and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
17. Bartlett GJ. Medical microbiology: quality cost and clinical relevance. John Wiley and Sons. New York 1974:27.
18. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Microbiology. 7th Ed. ASM Press Washington DC, 1999.
19. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Fourth Edition: approved standard M7-A5 (2001) and M100-S11 (2001) NCCLS, Wayne, PA.
20. Ball P. Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations. Chest 1995;108:43S-52S.
21. Sethi S. Related infectious exacerbations of chronic bronchitis: diagnosis and management. J Antimicrob Chemother 1999;43SupplA:97-105.
22. Tager I, Speizer FE. Role of infection in chronic bronchitis. N Engl J Med 1975;292:563-571.
23. Fagon JY, Chastre J. Severe exacerbations of COPD patients: the role of pulmonary infections. Semin Respir Infect 1996;11:109-118.
24. Chodosh S. Bronchitis and asthma. In Gorbach SL, Bartlett JG, Blacklow NR eds. Infectious diseases. Philadelphia, WB Saunders 1992:476-485.
25. Sohy C, Pilette C, Niederman MS, Sibille Y. Acute exacerbation of chronic pulmonary disease and antibiotics: what studies are still needed? Eur Resp J 2002;19:966-975.
26. Sethy S, Evans N, Grant BJB, Murphy T. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-471.
27. Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJB, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000;118:1557-1565.
28. 1-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 1999;160:1968-1975.
29. Yi K, Sethi S, Murphy TF. Human immune response to non-typeable Haemophilus influenzae in chronic bronchitis. J Infect Dis 1997;176:1247-1252.
30. Fagon JY, Chastre J, Trouillet JL, Domart Y, Dombret MC, Bornet M, Gibert C. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990;142:1004-1008.
31. Monsó E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, Ausina V. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152:1316-1320.
32. Hall CS, Kyprianou A, Fein AM. Acute exacerbations in chronic obstructive pulmonary disease: current strategies with pharmacological therapy. Drugs 2003;63:1481-1488.
33. Obaji A, Sethi S. Acute exacerbations of chronic bronchitis: what role for the new fluoroquinolones? Drugs Aging 2001;18:1-11.
34. Miravittles M, Espinosa C, Fernández-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999;116:40-46.
35. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis. Relation between bacteriologic etiology and lung function. Chest 1998;113:1542-1548.
36. Gompertz S, O'Bryen C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbation of chronic bronchitis. Eur Respir J 2001;17:1112-1119.
37. Murphy TE, Sethi S, Niederman MS. The role of bacteria in exacerbations of COPD. A constructive view. Chest 2000;118:204-209.
38. Smith CB, Golden CA, Kanner RE, Renzetti AD. Haemophilus influenzae and Haemophilus parainfluenzae in chronic obstructive pulmonary disease. Lancet 1976;1:1253-1255.
39. Deabate CA, Russell M, McElvaine P, Faris H, Upchurch J, Fowler CL, Polak EM, Morgan NS. Safety and efficacy of oral levofloxacin versus cefuroxime axetil in acute bacterial exacerbation of chronic bronchitis. Respir Care 1997;42:206-213.
40. Kilian M, Schiott CR. Haemophili and related bacteria in the human oral cavity. Arch Oral Biol 1975;20:791-796.
41. Foweraker JE, Cooke NJ, Hawkey PM. Ecology of Haemophilus influenzae and Haemophilus parainfluenzae in sputum and saliva and effects of antibiotics on their distribution in patients with lower respiratory tract infections. Antimicrob Agents Chemother 1993;37:804-809.
42. Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, Hernandez C, Rodriguez-Roisin R. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998;157:1498-1505.
43. Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, Jones PW. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006;61:284-289.
44. Gruppo di lavoro PROTEKT Italia. Studio di monitoraggio microbiologico per il rilevamento delle resistenze ai farmaci antimicrobici nei patogeni batterici delle vie respiratorie Protekt Italia. Risultati degli anni 2002 - 2003. GIMMOC 2004;8:193-256.
45. Schentag JJ, Tillotson GS. Antibiotic selection and dosing for the treatment of acute exacerbations of COPD. Chest 1997;112(6 Suppl):314S-319S.
46. Cunha BA. Antibiotic pharmacokinetic considerations in pulmonary infections. Semin Respir Infect 1991;6:168-182.